Douglas J. Biedenbach

Overview

Best Publications

• Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)

  Douglas J. Biedenbach;Gary J. Moet;Ronald N. Jones

  624
  Citations

• Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

  Mark A. Toleman;Alan M. Simm;Tanya A. Murphy;Ana C. Gales

  523
  Citations

• Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)

  Gary J. Moet;Ronald N. Jones;Douglas J. Biedenbach;Matthew G. Stilwell

  512
  Citations

• Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program

  Lalitagauri M. Deshpande;Thomas R. Fritsche;Gary J. Moet;Douglas J. Biedenbach

  474
  Citations

• A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

  Unknown

  291
  Citations

• A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

  Sujata M. Bhavnani;Julie A. Drake;Alan Forrest;June A. Deinhart

  257
  Citations

• Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

  Krystyna M. Kazmierczak;Sharon Rabine;Meredith Hackel;Robert E. McLaughlin

  249
  Citations

• Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

  Ronald N Jones;Charles H Ballow;Douglas J Biedenbach;June A Deinhart

  234
  Citations

• Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).

  Daryl J Hoban;Douglas J Biedenbach;Alan H Mutnick;Ronald N Jones

  188
  Citations

• In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)

  Boudewijn L. M. de Jonge;James A. Karlowsky;Krystyna M. Kazmierczak;Douglas J. Biedenbach

  187
  Citations

• In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci

  Ronald N. Jones;Lalitagauri M. Deshpande;Alan H. Mutnick;Douglas J. Biedenbach

  182
  Citations

• Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

  Ronald N Jones;Holly K Huynh;Douglas J Biedenbach;Thomas R Fritsche

  182
  Citations

• In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases

  Douglas J Biedenbach;Mondell L Beach;Ronald N Jones

  165
  Citations

• In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013

  Douglas J. Biedenbach;Krystyna Kazmierczak;Samuel K. Bouchillon;Daniel F. Sahm

  163
  Citations

• Activities of doripenem (S-4661) against drug-resistant clinical pathogens.

  Ronald N. Jones;Holly K. Huynh;Douglas J. Biedenbach

  161
  Citations

• In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

  D. J. Biedenbach;S. K. Bouchillon;M. Hackel;L. A. Miller

  155
  Citations

• Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme

  Mark A. Toleman;Doug Biedenbach;David M. C. Bennett;Ronald N. Jones

  155
  Citations

• Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.

  James A. Karlowsky;Douglas J. Biedenbach;Krystyna M. Kazmierczak;Gregory G. Stone

  144
  Citations

• Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program.

  Ronald N Jones;Phyllis Della-Latta;Lillian V Lee;Douglas J Biedenbach

  142
  Citations

• Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.

  Kelley A. Fedler;Douglas J. Biedenbach;Ronald N. Jones

  138
  Citations

• Genetic characterization of a novel metallo-β-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme

  Mark A. Toleman;Doug Biedenbach;David Bennett;Ronald N. Jones

  126
  Citations